APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pyrotinib

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pyrotinib Market Analysis and Forecast 2026-2032

23 December 2025193 pages

Choose your research edition.

Industry ResearchPyrotinib Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Pyrotinib Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Pyrotinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pyrotinib Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pyrotinib Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Pyrotinib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pyrotinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pyrotinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pyrotinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pyrotinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pyrotinib include Hengrui Pharmaceutical. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pyrotinib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pyrotinib, also provides the sales of main regions and countries. Of the upcoming market potential for Pyrotinib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pyrotinib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pyrotinib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pyrotinib sales, projected growth trends, production technology, application and end-user industry.

Pyrotinib Segment by Company

Hengrui Pharmaceutical

Pyrotinib Segment by Type

160mg Tables

80mg Tables

Pyrotinib Segment by Application

HER-2+ Advanced Breast Cancer

HER-3+ Metastatic Breast Cancer

Others

Pyrotinib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pyrotinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pyrotinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pyrotinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pyrotinib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pyrotinib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pyrotinib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pyrotinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 160mg Tables Major Manufacturers Table 3. 80mg Tables Major Manufacturers Table 4. Global Pyrotinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. HER-2+ Advanced Breast Cancer Major Manufacturers Table 6. HER-3+ Metastatic Breast Cancer Major Manufacturers Table 7. Others Major Manufacturers Table 8. Pyrotinib Industry Trends Table 9. Pyrotinib Industry Drivers Table 10. Pyrotinib Industry Opportunities and Challenges Table 11. Pyrotinib Industry Restraints Table 12. Global Pyrotinib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Pyrotinib Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Pyrotinib Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Pyrotinib Revenue Market Share by Region (2021-2026) Table 16. Global Pyrotinib Revenue Market Share by Region (2027-2032) Table 17. Global Pyrotinib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k pcs) Table 18. Global Pyrotinib Sales by Region (2021-2026) & (k pcs) Table 19. Global Pyrotinib Sales by Region (2027-2032) & (k pcs) Table 20. Global Pyrotinib Sales Market Share by Region (2021-2026) Table 21. Global Pyrotinib Sales Market Share by Region (2027-2032) Table 22. Global Pyrotinib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Pyrotinib Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Pyrotinib Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Pyrotinib Sales Market Share by Manufacturers (2021-2026) Table 26. Global Pyrotinib Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 27. Global Pyrotinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Pyrotinib Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Pyrotinib Manufacturers, Product Type & Application Table 30. Global Pyrotinib Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Pyrotinib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Pyrotinib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Pyrotinib Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Pyrotinib Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Pyrotinib Revenue Market Share by Type (2021-2026) Table 37. Global Pyrotinib Revenue Market Share by Type (2027-2032) Table 38. Global Pyrotinib Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 39. Global Pyrotinib Sales by Type (2021-2026) & (k pcs) Table 40. Global Pyrotinib Sales by Type (2027-2032) & (k pcs) Table 41. Global Pyrotinib Sales Market Share by Type (2021-2026) Table 42. Global Pyrotinib Sales Market Share by Type (2027-2032) Table 43. Global Pyrotinib Price by Type (2021-2026) & (US$/pcs) Table 44. Global Pyrotinib Price by Type (2027-2032) & (US$/pcs) Table 45. Global Pyrotinib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Pyrotinib Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Pyrotinib Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Pyrotinib Revenue Market Share by Application (2021-2026) Table 49. Global Pyrotinib Revenue Market Share by Application (2027-2032) Table 50. Global Pyrotinib Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 51. Global Pyrotinib Sales by Application (2021-2026) & (k pcs) Table 52. Global Pyrotinib Sales by Application (2027-2032) & (k pcs) Table 53. Global Pyrotinib Sales Market Share by Application (2021-2026) Table 54. Global Pyrotinib Sales Market Share by Application (2027-2032) Table 55. Global Pyrotinib Price by Application (2021-2026) & (US$/pcs) Table 56. Global Pyrotinib Price by Application (2027-2032) & (US$/pcs) Table 57. Hengrui Pharmaceutical Company Information Table 58. Hengrui Pharmaceutical Business Overview Table 59. Hengrui Pharmaceutical Pyrotinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 60. Hengrui Pharmaceutical Pyrotinib Product Portfolio Table 61. Hengrui Pharmaceutical Recent Development Table 62. North America Pyrotinib Revenue by Type (2021-2026) & (US$ Million) Table 63. North America Pyrotinib Revenue by Type (2027-2032) & (US$ Million) Table 64. North America Pyrotinib Sales by Type (2021-2026) & (k pcs) Table 65. North America Pyrotinib Sales by Type (2027-2032) & (k pcs) Table 66. North America Pyrotinib Sales Price by Type (2021-2026) & (US$/pcs) Table 67. North America Pyrotinib Sales Price by Type (2027-2032) & (US$/pcs) Table 68. North America Pyrotinib Revenue by Application (2021-2026) & (US$ Million) Table 69. North America Pyrotinib Revenue by Application (2027-2032) & (US$ Million) Table 70. North America Pyrotinib Sales by Application (2021-2026) & (k pcs) Table 71. North America Pyrotinib Sales by Application (2027-2032) & (k pcs) Table 72. North America Pyrotinib Sales Price by Application (2021-2026) & (US$/pcs) Table 73. North America Pyrotinib Sales Price by Application (2027-2032) & (US$/pcs) Table 74. North America Pyrotinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. North America Pyrotinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 76. North America Pyrotinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 77. North America Pyrotinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 78. North America Pyrotinib Sales by Country (2021-2026) & (k pcs) Table 79. North America Pyrotinib Sales by Country (2027-2032) & (k pcs) Table 80. North America Pyrotinib Sales Price by Country (2021-2026) & (US$/pcs) Table 81. North America Pyrotinib Sales Price by Country (2027-2032) & (US$/pcs) Table 82. United States Pyrotinib Revenue (2021-2032) & (US$ Million) Table 83. Canada Pyrotinib Revenue (2021-2032) & (US$ Million) Table 84. Mexico Pyrotinib Revenue (2021-2032) & (US$ Million) Table 85. Europe Pyrotinib Revenue by Type (2021-2026) & (US$ Million) Table 86. Europe Pyrotinib Revenue by Type (2027-2032) & (US$ Million) Table 87. Europe Pyrotinib Sales by Type (2021-2026) & (k pcs) Table 88. Europe Pyrotinib Sales by Type (2027-2032) & (k pcs) Table 89. Europe Pyrotinib Sales Price by Type (2021-2026) & (US$/pcs) Table 90. Europe Pyrotinib Sales Price by Type (2027-2032) & (US$/pcs) Table 91. Europe Pyrotinib Revenue by Application (2021-2026) & (US$ Million) Table 92. Europe Pyrotinib Revenue by Application (2027-2032) & (US$ Million) Table 93. Europe Pyrotinib Sales by Application (2021-2026) & (k pcs) Table 94. Europe Pyrotinib Sales by Application (2027-2032) & (k pcs) Table 95. Europe Pyrotinib Sales Price by Application (2021-2026) & (US$/pcs) Table 96. Europe Pyrotinib Sales Price by Application (2027-2032) & (US$/pcs) Table 97. Europe Pyrotinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Pyrotinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 99. Europe Pyrotinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 100. Europe Pyrotinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 101. Europe Pyrotinib Sales by Country (2021-2026) & (k pcs) Table 102. Europe Pyrotinib Sales by Country (2027-2032) & (k pcs) Table 103. Europe Pyrotinib Sales Price by Country (2021-2026) & (US$/pcs) Table 104. Europe Pyrotinib Sales Price by Country (2027-2032) & (US$/pcs) Table 105. Germany Pyrotinib Revenue (2021-2032) & (US$ Million) Table 106. France Pyrotinib Revenue (2021-2032) & (US$ Million) Table 107. U.K. Pyrotinib Revenue (2021-2032) & (US$ Million) Table 108. Italy Pyrotinib Revenue (2021-2032) & (US$ Million) Table 109. Russia Pyrotinib Revenue (2021-2032) & (US$ Million) Table 110. Spain Pyrotinib Revenue (2021-2032) & (US$ Million) Table 111. Netherlands Pyrotinib Revenue (2021-2032) & (US$ Million) Table 112. Switzerland Pyrotinib Revenue (2021-2032) & (US$ Million) Table 113. Sweden Pyrotinib Revenue (2021-2032) & (US$ Million) Table 114. Poland Pyrotinib Revenue (2021-2032) & (US$ Million) Table 115. China Pyrotinib Revenue by Type (2021-2026) & (US$ Million) Table 116. China Pyrotinib Revenue by Type (2027-2032) & (US$ Million) Table 117. China Pyrotinib Sales by Type (2021-2026) & (k pcs) Table 118. China Pyrotinib Sales by Type (2027-2032) & (k pcs) Table 119. China Pyrotinib Sales Price by Type (2021-2026) & (US$/pcs) Table 120. China Pyrotinib Sales Price by Type (2027-2032) & (US$/pcs) Table 121. China Pyrotinib Revenue by Application (2021-2026) & (US$ Million) Table 122. China Pyrotinib Revenue by Application (2027-2032) & (US$ Million) Table 123. China Pyrotinib Sales by Application (2021-2026) & (k pcs) Table 124. China Pyrotinib Sales by Application (2027-2032) & (k pcs) Table 125. China Pyrotinib Sales Price by Application (2021-2026) & (US$/pcs) Table 126. China Pyrotinib Sales Price by Application (2027-2032) & (US$/pcs) Table 127. Asia Pyrotinib Revenue by Type (2021-2026) & (US$ Million) Table 128. Asia Pyrotinib Revenue by Type (2027-2032) & (US$ Million) Table 129. Asia Pyrotinib Sales by Type (2021-2026) & (k pcs) Table 130. Asia Pyrotinib Sales by Type (2027-2032) & (k pcs) Table 131. Asia Pyrotinib Sales Price by Type (2021-2026) & (US$/pcs) Table 132. Asia Pyrotinib Sales Price by Type (2027-2032) & (US$/pcs) Table 133. Asia Pyrotinib Revenue by Application (2021-2026) & (US$ Million) Table 134. Asia Pyrotinib Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia Pyrotinib Sales by Application (2021-2026) & (k pcs) Table 136. Asia Pyrotinib Sales by Application (2027-2032) & (k pcs) Table 137. Asia Pyrotinib Sales Price by Application (2021-2026) & (US$/pcs) Table 138. Asia Pyrotinib Sales Price by Application (2027-2032) & (US$/pcs) Table 139. Asia Pyrotinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Asia Pyrotinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. Asia Pyrotinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. Asia Pyrotinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 143. Asia Pyrotinib Sales by Country (2021-2026) & (k pcs) Table 144. Asia Pyrotinib Sales by Country (2027-2032) & (k pcs) Table 145. Asia Pyrotinib Sales Price by Country (2021-2026) & (US$/pcs) Table 146. Asia Pyrotinib Sales Price by Country (2027-2032) & (US$/pcs) Table 147. Japan Pyrotinib Revenue (2021-2032) & (US$ Million) Table 148. South Korea Pyrotinib Revenue (2021-2032) & (US$ Million) Table 149. India Pyrotinib Revenue (2021-2032) & (US$ Million) Table 150. Australia Pyrotinib Revenue (2021-2032) & (US$ Million) Table 151. Taiwan Pyrotinib Revenue (2021-2032) & (US$ Million) Table 152. Southeast Asia Pyrotinib Revenue (2021-2032) & (US$ Million) Table 153. SAMEA Pyrotinib Revenue by Type (2021-2026) & (US$ Million) Table 154. SAMEA Pyrotinib Revenue by Type (2027-2032) & (US$ Million) Table 155. SAMEA Pyrotinib Sales by Type (2021-2026) & (k pcs) Table 156. SAMEA Pyrotinib Sales by Type (2027-2032) & (k pcs) Table 157. SAMEA Pyrotinib Sales Price by Type (2021-2026) & (US$/pcs) Table 158. SAMEA Pyrotinib Sales Price by Type (2027-2032) & (US$/pcs) Table 159. SAMEA Pyrotinib Revenue by Application (2021-2026) & (US$ Million) Table 160. SAMEA Pyrotinib Revenue by Application (2027-2032) & (US$ Million) Table 161. SAMEA Pyrotinib Sales by Application (2021-2026) & (k pcs) Table 162. SAMEA Pyrotinib Sales by Application (2027-2032) & (k pcs) Table 163. SAMEA Pyrotinib Sales Price by Application (2021-2026) & (US$/pcs) Table 164. SAMEA Pyrotinib Sales Price by Application (2027-2032) & (US$/pcs) Table 165. SAMEA Pyrotinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. SAMEA Pyrotinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. SAMEA Pyrotinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. SAMEA Pyrotinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 169. SAMEA Pyrotinib Sales by Country (2021-2026) & (k pcs) Table 170. SAMEA Pyrotinib Sales by Country (2027-2032) & (k pcs) Table 171. SAMEA Pyrotinib Sales Price by Country (2021-2026) & (US$/pcs) Table 172. SAMEA Pyrotinib Sales Price by Country (2027-2032) & (US$/pcs) Table 173. Brazil Pyrotinib Revenue (2021-2032) & (US$ Million) Table 174. Argentina Pyrotinib Revenue (2021-2032) & (US$ Million) Table 175. Chile Pyrotinib Revenue (2021-2032) & (US$ Million) Table 176. Colombia Pyrotinib Revenue (2021-2032) & (US$ Million) Table 177. Peru Pyrotinib Revenue (2021-2032) & (US$ Million) Table 178. Saudi Arabia Pyrotinib Revenue (2021-2032) & (US$ Million) Table 179. Israel Pyrotinib Revenue (2021-2032) & (US$ Million) Table 180. UAE Pyrotinib Revenue (2021-2032) & (US$ Million) Table 181. Turkey Pyrotinib Revenue (2021-2032) & (US$ Million) Table 182. Iran Pyrotinib Revenue (2021-2032) & (US$ Million) Table 183. Egypt Pyrotinib Revenue (2021-2032) & (US$ Million) Table 184. Key Raw Materials Table 185. Raw Materials Key Suppliers Table 186. Pyrotinib Distributors List Table 187. Pyrotinib Customers List Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Pyrotinib Image Figure 2. Global Pyrotinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pyrotinib Market Size Share 2021 VS 2025 VS 2032 Figure 4. 160mg Tables Image Figure 5. 80mg Tables Image Figure 6. Global Pyrotinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pyrotinib Market Size Share 2021 VS 2025 VS 2032 Figure 8. HER-2+ Advanced Breast Cancer Image Figure 9. HER-3+ Metastatic Breast Cancer Image Figure 10. Others Image Figure 11. Global Pyrotinib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Pyrotinib Revenue (2021-2032) & (US$ Million) Figure 13. Global Pyrotinib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Pyrotinib Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Pyrotinib Revenue Market Share by Region (2021-2032) Figure 16. Global Pyrotinib Sales (2021-2032) & (k pcs) Figure 17. Global Pyrotinib Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 18. Global Pyrotinib Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Pyrotinib Sales YoY (2021-2032) & (k pcs) Figure 20. Europe Pyrotinib Sales YoY (2021-2032) & (k pcs) Figure 21. China Pyrotinib Sales YoY (2021-2032) & (k pcs) Figure 22. Asia (Excluding China) Pyrotinib Sales YoY (2021-2032) & (k pcs) Figure 23. South America, Middle East and Africa Pyrotinib Sales YoY (2021-2032) & (k pcs) Figure 24. Global Pyrotinib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Pyrotinib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Pyrotinib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Pyrotinib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Pyrotinib Revenue Market Share by Type (2021-2032) Figure 30. Global Pyrotinib Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 31. Global Pyrotinib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Pyrotinib Sales Market Share by Type (2021-2032) Figure 33. Global Pyrotinib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Pyrotinib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Pyrotinib Revenue Market Share by Application (2021-2032) Figure 36. Global Pyrotinib Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 37. Global Pyrotinib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Pyrotinib Sales Market Share by Application (2021-2032) Figure 39. North America Pyrotinib Revenue Share by Type (2021-2032) Figure 40. North America Pyrotinib Sales Share by Type (2021-2032) Figure 41. North America Pyrotinib Revenue Share by Application (2021-2032) Figure 42. North America Pyrotinib Sales Share by Application (2021-2032) Figure 43. North America Pyrotinib Revenue Share by Country (2021-2032) Figure 44. North America Pyrotinib Sales Share by Country (2021-2032) Figure 45. Europe Pyrotinib Revenue Share by Type (2021-2032) Figure 46. Europe Pyrotinib Sales Share by Type (2021-2032) Figure 47. Europe Pyrotinib Revenue Share by Application (2021-2032) Figure 48. Europe Pyrotinib Sales Share by Application (2021-2032) Figure 49. Europe Pyrotinib Revenue Share by Country (2021-2032) Figure 50. Europe Pyrotinib Sales Share by Country (2021-2032) Figure 51. China Pyrotinib Revenue Share by Type (2021-2032) Figure 52. China Pyrotinib Sales Share by Type (2021-2032) Figure 53. China Pyrotinib Revenue Share by Application (2021-2032) Figure 54. China Pyrotinib Sales Share by Application (2021-2032) Figure 55. Asia Pyrotinib Revenue Share by Type (2021-2032) Figure 56. Asia Pyrotinib Sales Share by Type (2021-2032) Figure 57. Asia Pyrotinib Revenue Share by Application (2021-2032) Figure 58. Asia Pyrotinib Sales Share by Application (2021-2032) Figure 59. Asia Pyrotinib Revenue Share by Country (2021-2032) Figure 60. Asia Pyrotinib Sales Share by Country (2021-2032) Figure 61. SAMEA Pyrotinib Revenue Share by Type (2021-2032) Figure 62. SAMEA Pyrotinib Sales Share by Type (2021-2032) Figure 63. SAMEA Pyrotinib Revenue Share by Application (2021-2032) Figure 64. SAMEA Pyrotinib Sales Share by Application (2021-2032) Figure 65. SAMEA Pyrotinib Revenue Share by Country (2021-2032) Figure 66. SAMEA Pyrotinib Sales Share by Country (2021-2032) Figure 67. Pyrotinib Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Pyrotinib Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 160mg Tables
  • 80mg Tables
Applications
  • HER-2+ Advanced Breast Cancer
  • HER-3+ Metastatic Breast Cancer
  • Others
Companies covered
  • Hengrui Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pyrotinib Market by Type
  3. 1.2.1 Global Pyrotinib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 160mg Tables
  5. 1.2.3 80mg Tables
  6. 1.3 Pyrotinib Market by Application
  7. 1.3.1 Global Pyrotinib Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 HER-2+ Advanced Breast Cancer
  9. 1.3.3 HER-3+ Metastatic Breast Cancer
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Pyrotinib Market Dynamics
  1. 2.1 Pyrotinib Industry Trends
  2. 2.2 Pyrotinib Industry Drivers
  3. 2.3 Pyrotinib Industry Opportunities and Challenges
  4. 2.4 Pyrotinib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pyrotinib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pyrotinib Revenue by Region
  3. 3.2.1 Global Pyrotinib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pyrotinib Revenue by Region (2021-2026)
  5. 3.2.3 Global Pyrotinib Revenue by Region (2027-2032)
  6. 3.2.4 Global Pyrotinib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pyrotinib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pyrotinib Sales by Region
  9. 3.4.1 Global Pyrotinib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pyrotinib Sales by Region (2021-2026)
  11. 3.4.3 Global Pyrotinib Sales by Region (2027-2032)
  12. 3.4.4 Global Pyrotinib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pyrotinib Revenue by Manufacturers
  2. 4.1.1 Global Pyrotinib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pyrotinib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pyrotinib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pyrotinib Sales by Manufacturers
  6. 4.2.1 Global Pyrotinib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pyrotinib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pyrotinib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pyrotinib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pyrotinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pyrotinib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pyrotinib Manufacturers, Product Type & Application
  13. 4.7 Global Pyrotinib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pyrotinib Market CR5 and HHI
  16. 4.8.2 2025 Pyrotinib Tier 1, Tier 2, and Tier 3
5 Pyrotinib Market by Type
  1. 5.1 Global Pyrotinib Revenue by Type
  2. 5.1.1 Global Pyrotinib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pyrotinib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pyrotinib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pyrotinib Sales by Type
  6. 5.2.1 Global Pyrotinib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pyrotinib Sales by Type (2021-2032) & (k pcs)
  8. 5.2.3 Global Pyrotinib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pyrotinib Price by Type
6 Pyrotinib Market by Application
  1. 6.1 Global Pyrotinib Revenue by Application
  2. 6.1.1 Global Pyrotinib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pyrotinib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pyrotinib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pyrotinib Sales by Application
  6. 6.2.1 Global Pyrotinib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pyrotinib Sales by Application (2021-2032) & (k pcs)
  8. 6.2.3 Global Pyrotinib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pyrotinib Price by Application
7 Company Profiles
  1. 7.1 Hengrui Pharmaceutical
  2. 7.1.1 Hengrui Pharmaceutical Company Information
  3. 7.1.2 Hengrui Pharmaceutical Business Overview
  4. 7.1.3 Hengrui Pharmaceutical Pyrotinib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Hengrui Pharmaceutical Pyrotinib Product Portfolio
  6. 7.1.5 Hengrui Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Pyrotinib Market Size by Type
  2. 8.1.1 North America Pyrotinib Revenue by Type (2021-2032)
  3. 8.1.2 North America Pyrotinib Sales by Type (2021-2032)
  4. 8.1.3 North America Pyrotinib Price by Type (2021-2032)
  5. 8.2 North America Pyrotinib Market Size by Application
  6. 8.2.1 North America Pyrotinib Revenue by Application (2021-2032)
  7. 8.2.2 North America Pyrotinib Sales by Application (2021-2032)
  8. 8.2.3 North America Pyrotinib Price by Application (2021-2032)
  9. 8.3 North America Pyrotinib Market Size by Country
  10. 8.3.1 North America Pyrotinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pyrotinib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pyrotinib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pyrotinib Market Size by Type
  2. 9.1.1 Europe Pyrotinib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pyrotinib Sales by Type (2021-2032)
  4. 9.1.3 Europe Pyrotinib Price by Type (2021-2032)
  5. 9.2 Europe Pyrotinib Market Size by Application
  6. 9.2.1 Europe Pyrotinib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pyrotinib Sales by Application (2021-2032)
  8. 9.2.3 Europe Pyrotinib Price by Application (2021-2032)
  9. 9.3 Europe Pyrotinib Market Size by Country
  10. 9.3.1 Europe Pyrotinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pyrotinib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pyrotinib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pyrotinib Market Size by Type
  2. 10.1.1 China Pyrotinib Revenue by Type (2021-2032)
  3. 10.1.2 China Pyrotinib Sales by Type (2021-2032)
  4. 10.1.3 China Pyrotinib Price by Type (2021-2032)
  5. 10.2 China Pyrotinib Market Size by Application
  6. 10.2.1 China Pyrotinib Revenue by Application (2021-2032)
  7. 10.2.2 China Pyrotinib Sales by Application (2021-2032)
  8. 10.2.3 China Pyrotinib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pyrotinib Market Size by Type
  2. 11.1.1 Asia Pyrotinib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pyrotinib Sales by Type (2021-2032)
  4. 11.1.3 Asia Pyrotinib Price by Type (2021-2032)
  5. 11.2 Asia Pyrotinib Market Size by Application
  6. 11.2.1 Asia Pyrotinib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pyrotinib Sales by Application (2021-2032)
  8. 11.2.3 Asia Pyrotinib Price by Application (2021-2032)
  9. 11.3 Asia Pyrotinib Market Size by Country
  10. 11.3.1 Asia Pyrotinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pyrotinib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pyrotinib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pyrotinib Market Size by Type
  2. 12.1.1 SAMEA Pyrotinib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pyrotinib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pyrotinib Price by Type (2021-2032)
  5. 12.2 SAMEA Pyrotinib Market Size by Application
  6. 12.2.1 SAMEA Pyrotinib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pyrotinib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pyrotinib Price by Application (2021-2032)
  9. 12.3 SAMEA Pyrotinib Market Size by Country
  10. 12.3.1 SAMEA Pyrotinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pyrotinib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pyrotinib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pyrotinib Value Chain Analysis
  2. 13.1.1 Pyrotinib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pyrotinib Production Mode & Process
  6. 13.2 Pyrotinib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pyrotinib Distributors
  9. 13.2.3 Pyrotinib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst